CEL-SCI (CVM) News Today $0.39 -0.01 (-2.21%) Closing price 04:00 PM EasternExtended Trading$0.39 +0.00 (+0.08%) As of 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period CEL-SCI (NYSE:CVM) Coverage Initiated at StockNews.comJanuary 19 at 2:36 AM | americanbankingnews.comCEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck CancerJanuary 14, 2025 | finance.yahoo.comCEL-SCI (AMEX:CVM) Stock Quotes, Forecast and News SummaryDecember 31, 2024 | benzinga.comWhat's Going On With Cel-Sci Shares Premarket On Monday?December 30, 2024 | benzinga.comCEL-SCI prices $5M public offering at 31c per shareDecember 30, 2024 | markets.businessinsider.comCEL-SCI prices $5 million offeringDecember 30, 2024 | msn.comCel-Sci Stock Slips After Public Offering: Retail's NeutralDecember 30, 2024 | msn.comCEL-SCI Prices Public Offering Of 16.13 Mln Shares At $0.31/shrDecember 29, 2024 | markets.businessinsider.comCEL-SCI Announces Pricing of $5 Million Public OfferingDecember 29, 2024 | businesswire.comCEL-SCI announces common stock offering, no amount givenDecember 27, 2024 | msn.comCEL-SCI Announces Proposed Public Offering of Common StockDecember 27, 2024 | businesswire.comCEL-SCI provides rationale for use of Multikine in head, neck cancer studyDecember 13, 2024 | markets.businessinsider.comCVM: CRO Selected for Registrational TrialDecember 9, 2024 | msn.comU.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025November 7, 2024 | finance.yahoo.com3 Interesting Emerging Growth Stock Ideas From the 2024 Think Equity ConferenceNovember 4, 2024 | investing.comCEL-SCI files to sell 1M shares of common stock for holdersOctober 25, 2024 | markets.businessinsider.comUpstream Bio Inc.October 14, 2024 | money.usnews.comCalcium-mediated effect plays key role in cell disposal, researchers discoverOctober 11, 2024 | msn.comCEL-SCI (NYSE:CVM) Trading Down 3.8% - Here's What HappenedCEL-SCI (NYSE:CVM) Stock Price Down 3.8% - Time to Sell?October 11, 2024 | marketbeat.comCEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck CancerOctober 1, 2024 | finance.yahoo.comCVM Oct 2024 2.000 callSeptember 21, 2024 | ca.finance.yahoo.comCEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 CongressSeptember 10, 2024 | finance.yahoo.comCVM Jan 2025 1.500 callAugust 30, 2024 | ca.finance.yahoo.comCVM Sep 2024 1.500 callAugust 29, 2024 | ca.finance.yahoo.comCVM Oct 2024 1.500 callAugust 29, 2024 | ca.finance.yahoo.comCVM Apr 2025 1.000 putAugust 29, 2024 | ca.finance.yahoo.comCVM: Start Your Engines – FDA Green Lights Confirmatory Registration StudyAugust 28, 2024 | finance.yahoo.comCVM Oct 2024 0.500 call (CVM241018C00000500)August 28, 2024 | finance.yahoo.comCVM Oct 2024 1.500 put (CVM241018P00001500)August 28, 2024 | finance.yahoo.comCVM Sep 2024 1.000 callAugust 23, 2024 | ca.finance.yahoo.comPrincipal Investment Grd Corp Actv ETF (IG)August 23, 2024 | uk.finance.yahoo.comBiomotion Sciences.August 21, 2024 | money.usnews.comNew tool simplifies cell tracking data analysisAugust 17, 2024 | msn.comCEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial ResultsAugust 15, 2024 | stockhouse.com3 Penny Stocks to Watch Now, 7/30/24July 30, 2024 | msn.comCEL-SCI Announces Closing of $10.8 Million OfferingJuly 29, 2024 | finance.yahoo.com(SANSTAR.BO)July 27, 2024 | finance.yahoo.comStock Traders Purchase High Volume of Call Options on CEL-SCI (NYSE:CVM)CEL-SCI Co. (NYSE:CVM - Get Free Report) was the target of unusually large options trading activity on Friday. Traders acquired 2,966 call options on the stock. This is an increase of approximately 986% compared to the typical daily volume of 273 call options.July 26, 2024 | marketbeat.comCEL-SCI Announces Pricing of $10.8 Million OfferingJuly 26, 2024 | finance.yahoo.comNewly identified immune cell switch could control inflammationJuly 25, 2024 | msn.comNew model explains precise timing of viral cell burstingJuly 21, 2024 | msn.comCVI Holdings LLC Invests $1.68 Million in CEL-SCI Co. (NYSE:CVM)CVI Holdings LLC purchased a new position in shares of CEL-SCI Co. (NYSE:CVM - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 878,767 shares of the company's stock, valued at approximaJuly 14, 2024 | marketbeat.comCEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target PopulationJune 18, 2024 | businesswire.comDr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical AdvisorJune 6, 2024 | businesswire.comCel-Sci Corp.May 22, 2024 | money.usnews.comCVM: Confirmatory Study ClarityMay 21, 2024 | finance.yahoo.comCEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial ResultsMay 16, 2024 | businesswire.comInsider Buying: CEL-SCI Co. (NYSE:CVM) Director Acquires 20,000 Shares of StockMay 11, 2024 | insidertrades.comCEL-SCI Co. (NYSE:CVM) SVP Acquires $11,120.00 in StockMay 10, 2024 | insidertrades.comCEL-SCI Co. (NYSE:CVM) Director Acquires $27,800.00 in StockCEL-SCI Co. (NYSE:CVM - Get Free Report) Director Robert Eugene Watson bought 20,000 shares of the firm's stock in a transaction on Wednesday, May 8th. The stock was acquired at an average cost of $1.39 per share, with a total value of $27,800.00. Following the completion of the purchase, the director now owns 24,431 shares of the company's stock, valued at approximately $33,959.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.May 10, 2024 | marketbeat.com Get CEL-SCI News Delivered to You Automatically Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter. Email Address CVM Media Mentions By Week CVM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVM News Sentiment▼0.490.57▲Average Medical News Sentiment CVM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVM Articles This Week▼21▲CVM Articles Average Week Get CEL-SCI News Delivered to You Automatically Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XBiotech News Today Zura Bio News Today Inventiva News Today Renovaro News Today Enanta Pharmaceuticals News Today Tenaya Therapeutics News Today Elutia News Today Nuvectis Pharma News Today Milestone Pharmaceuticals News Today IGM Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CVM) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CEL-SCI Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CEL-SCI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.